Whalegun
Home

Travere Therapeutics TVTX paid Alston & Bird $80K for lobbying in Q1 2026 · Pharmacy, Health Issues and 3 more issues

Trade details

Type
Lobbying report
Amount
$80,000
Quarter
Q1 2026
Stock
Travere Therapeutics TVTX
Client
Travere Therapeutics
Reported
26/04/20

Up 0.0% from last quarter

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Travere Therapeutics's other lobbying reports

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $16K

    Reported 08/04

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $70K

    Reported 07/20

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $140K

    Reported 07/20

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $16K

    Reported 05/19

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $200K

    Reported 04/20